Wei Yusen, Mao Jiangdi, Tang Wenjie, Ma Yanfei, Li Jiachen, Su Songtao, Ni Zhixiang, Wu Jinhong, Liu Daren, Wang Haifeng
The Key Laboratory of Molecular Animal Nutrition, Ministry of Education, College of Animal Science, Zhejiang University, Hangzhou 310058, China.
The Second Affiliated Hospital of Zhejiang University, Department of Hepatobiliary and Pancreatic Surgery, Hangzhou 310009, China.
ISME J. 2025 Jan 2;19(1). doi: 10.1093/ismejo/wraf141.
Male offspring with intrauterine growth restriction (IUGR) exhibit more pronounced hepatic lipid metabolism abnormalities than females, necessitating earlier intervention. Icariin (ICA) has been shown to effectively modulate hepatic lipid metabolism in male piglets with IUGR. However, the role of gut microbiota in this process remains to be elucidated. This study aimed to explore the influence of gut microbiota on ICA-induced enhancement of hepatic lipid metabolism. By examining changes in microbiota composition and hepatic lipid metabolism following ICA intervention, the study demonstrated an association between microbial alterations and hepatic lipid regulation through fecal microbiota transplantation. The impact of Catenibacterium on gut microbiota structure and hepatic lipid metabolism was assessed in vivo, and the direct effect of ICA on Catenibacterium was explored in vitro. Results revealed that ICA intervention modified fecal, ileal, and colonic microbiota in male piglets with IUGR, enhanced gut morphology and barrier function, and normalized the expression of hepatic peroxisome proliferator-activated receptor signaling pathway-related genes. Fecal microbiota transplantation from piglets with IUGR impaired intestinal barrier function and led to hepatic lipid deposition, whereas transplantation from ICA-treated donors showed no pathological changes, an outcome associated with reduced abundance of Catenibacterium. Mechanistically, ICA inhibits adenosine triphosphate synthesis to suppress Catenibacterium, remodels gut microbiota, reduces lipopolysaccharide production and translocation, and activates the hepatic PPARα/CD36 axis. In conclusion, ICA intervention alleviates hepatic lipid metabolic disorders in male offspring with IUGR by suppressing Catenibacterium, restoring gut microbial balance, and enhancing intestinal barrier integrity to limit lipopolysaccharide translocation.
宫内生长受限(IUGR)的雄性后代比雌性表现出更明显的肝脏脂质代谢异常,因此需要更早进行干预。淫羊藿苷(ICA)已被证明能有效调节IUGR雄性仔猪的肝脏脂质代谢。然而,肠道微生物群在此过程中的作用仍有待阐明。本研究旨在探讨肠道微生物群对ICA诱导的肝脏脂质代谢增强的影响。通过检查ICA干预后微生物群组成和肝脏脂质代谢的变化,该研究通过粪便微生物群移植证明了微生物改变与肝脏脂质调节之间的关联。在体内评估了链状杆菌对肠道微生物群结构和肝脏脂质代谢的影响,并在体外探索了ICA对链状杆菌的直接作用。结果显示,ICA干预改变了IUGR雄性仔猪的粪便、回肠和结肠微生物群,增强了肠道形态和屏障功能,并使肝脏过氧化物酶体增殖物激活受体信号通路相关基因的表达正常化。IUGR仔猪的粪便微生物群移植损害了肠道屏障功能并导致肝脏脂质沉积,而来自ICA处理供体的移植则未显示出病理变化,这一结果与链状杆菌丰度降低有关。从机制上讲,ICA抑制三磷酸腺苷合成以抑制链状杆菌,重塑肠道微生物群,减少脂多糖的产生和易位,并激活肝脏PPARα/CD36轴。总之,ICA干预通过抑制链状杆菌、恢复肠道微生物平衡和增强肠道屏障完整性以限制脂多糖易位,减轻了IUGR雄性后代的肝脏脂质代谢紊乱。